Silverarc Capital Management LLC 购买了 Scholar Rock Holding Co. 的股份。 Silverarc Capital Management LLC purchased shares of Scholar Rock Holding Co.

Silverarc Capital Management LLC 在第三季度以 69,000 美元的投资购买了 Scholar Rock Holding Co.（纳斯达克股票代码：SRRK）的 9,711 股股票。 Silverarc Capital Management LLC purchased 9,711 shares of Scholar Rock Holding Co. (NASDAQ:SRRK) for a $69,000 investment in Q3. 加拿大皇家银行和联合银行等其他投资者也增持了 SRRK 的股份。 Other investors, such as Royal Bank of Canada and Amalgamated Bank, also increased their stakes in SRRK. Silverarc 持有多家生物技术公司的股份，包括 Evogene、Roivant Sciences、Karyopharm Therapeutics、Aerovate Therapeutics 和 Viridian Therapeutics。 Silverarc has holdings in various biotech companies, including Evogene, Roivant Sciences, Karyopharm Therapeutics, Aerovate Therapeutics, and Viridian Therapeutics.